Johnson & Johnson MedTech reported 4.6% growth in Q1, driven by a strong pipeline of cardiovascular and surgical innovations.

Jabil and HSE have formed a strategic collaboration to streamline the design, development, and scalable production of ...

In the past 18 months, the FDA has outlined clear guidelines for designing, documenting, updating, and monitoring AI-powered ...

Explore the factors that made intellectual property such a hot medtech topic in 1996 and the current role of IP in the ...

MD+DI Senior Editor Amanda Pedersen highlights FDA's use of a chief medical officer's name in a recent warning letter to ExThera for unapproved claims.

Michael McGee, CEO of Freudenberg Medical, shares how AI reduces development iterations, robotics upskill workers, and ...

StairMed raises $73M from Alibaba and Tencent for brain-computer interface development and plans 40 patient implants by 2026 ...

Medical Device OEMs are looking to simplify relationships with suppliers by contracting with fewer vendors who can handle ...

Retractable Technologies is cutting 16% of its workforce to save $2.2 million annually and strengthen domestic production.

Pulse Biosciences is keeping the noise level up by announcing the enrollment of the first patients in the NANOPULSE-AF study, ...

L.E.K. Consultants will discuss the major forces shaping the CMO market in this upcoming webinar hosted by MD+DI and ...

Rhythm Technologies CFO Daniel Wilson joins us on this episode of Let's Talk Medtech to discuss the company's expansion into ...